Peptide vaccines in cancer-old concept revisited.
作者： Takumi Kumai , Hiroya Kobayashi , Yasuaki Harabuchi , Esteban Celis
DOI: 10.1016/J.COI.2016.11.001
关键词:
摘要: … trials using peptide vaccines have been disappointing. Thus, many researchers in the field have considered peptide vaccines as outdated and no longer viable for cancer therapy. …
elsevier.com
sci-hub.se 参考文章(68)
Zili Wang, Esteban Celis, STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice. Cancer Immunology, Immunotherapy. ,vol. 64, pp. 1057- 1066 ,(2015) , 10.1007/S00262-015-1713-5
Yi Wen, Joel H Collier, Supramolecular peptide vaccines: tuning adaptive immunity. Current Opinion in Immunology. ,vol. 35, pp. 73- 79 ,(2015) , 10.1016/J.COI.2015.06.007
Martijn S. Bijker, Susan J. F. van den Eeden, Kees L. Franken, Cornelis J. M. Melief, Rienk Offringa, Sjoerd H. van der Burg, CD8+ CTL Priming by Exact Peptide Epitopes in Incomplete Freund’s Adjuvant Induces a Vanishing CTL Response, whereas Long Peptides Induce Sustained CTL Reactivity Journal of Immunology. ,vol. 179, pp. 5033- 5040 ,(2007) , 10.4049/JIMMUNOL.179.8.5033
Cheng-Hong Wei, Linda A. Sherman, N-Terminal Trimer Extension of Nominal CD8 T Cell Epitopes Is Sufficient to Promote Cross-Presentation to Cognate CD8 T Cells In Vivo The Journal of Immunology. ,vol. 179, pp. 8280- 8286 ,(2007) , 10.4049/JIMMUNOL.179.12.8280
Stephen P. Schoenberger, Rene E. M. Toes, Ellen I. H. van der Voort, Rienk Offringa, Cornelis J. M. Melief, T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions Nature. ,vol. 393, pp. 480- 483 ,(1998) , 10.1038/31002
Gail D. Sckisel, Myriam N. Bouchlaka, Arta M. Monjazeb, Marka Crittenden, Brendan D. Curti, Danice E.C. Wilkins, Kory A. Alderson, Can M. Sungur, Erik Ames, Annie Mirsoian, Abhinav Reddy, Warren Alexander, Athena Soulika, Bruce R. Blazar, Dan L. Longo, Robert H. Wiltrout, William J. Murphy, Out-of-Sequence Signal 3 Paralyzes Primary CD4+ T-Cell-Dependent Immunity Immunity. ,vol. 43, pp. 240- 250 ,(2015) , 10.1016/J.IMMUNI.2015.06.023
Deepa K. Krishnadas, Suzanne Shusterman, Fanqi Bai, Lisa Diller, Janice E. Sullivan, Alexandra C. Cheerva, Rani E. George, Kenneth G. Lucas, A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma Cancer Immunology, Immunotherapy. ,vol. 64, pp. 1251- 1260 ,(2015) , 10.1007/S00262-015-1731-3
Susanne Hofmann, Andrew Mead, Aleksandrs Malinovskis, Nicola R. Hardwick, Barbara-ann Guinn, Analogue peptides for the immunotherapy of human acute myeloid leukemia Cancer Immunology, Immunotherapy. ,vol. 64, pp. 1357- 1367 ,(2015) , 10.1007/S00262-015-1762-9
Jane E. Willoughby, Jonathan P. Kerr, Anne Rogel, Vadim Y. Taraban, Sarah L. Buchan, Peter W. M. Johnson, Aymen Al-Shamkhani, Differential impact of CD27 and 4-1BB costimulation on effector and memory CD8 T cell generation following peptide immunization Journal of Immunology. ,vol. 193, pp. 244- 251 ,(2014) , 10.4049/JIMMUNOL.1301217
Jamie B Spangler, Jakub Tomala, Vincent C Luca, Kevin M Jude, Shen Dong, Aaron M Ring, Petra Votavova, Marion Pepper, Marek Kovar, K Christopher Garcia, None, Antibodies to Interleukin-2 elicit selective T cell subset potentiation through distinct conformational mechanisms Immunity. ,vol. 42, pp. 815- 825 ,(2015) , 10.1016/J.IMMUNI.2015.04.015